QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth

Author:

Kim Eun Ju1,Kim Jeong Seon1,Lee Sieun1,Lee Heejin2,Yoon Jung‐Sook3,Hong Ji Hyung4,Chun Sang Hoon4,Sun Der Sheng4,Won Hye Sung4,Hong Soon Auck5,Kang Keunsoo6,Jo Jeong Yeon7,Choi Minyoung7,Shin Dong Hoon7,Ahn Young‐Ho1ORCID,Ko Yoon Ho24

Affiliation:

1. Department of Molecular Medicine and Tissue Injury Defense Research Center, College of MedicineEwha Womans University Seoul South Korea

2. Cancer Research Institute, College of Medicine, The Catholic University of Korea Seoul South Korea

3. Clinical Research LaboratoryUijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea Uijeongbu Gyeonggi South Korea

4. Division of Oncology, Department of Internal MedicineCollege of Medicine, The Catholic University of Korea Seoul South Korea

5. Department of Pathology, College of MedicineChung‐Ang University Seoul South Korea

6. Department of Microbiology, College of Natural SciencesDankook University, Cheonan Chungnam South Korea

7. Research Institute and Department of Cancer Biomedical Science, Graduate School of Cancer Science and PolicyNational Cancer Center Goyang Gyeonggi South Korea

Funder

National Research Foundation of Korea

Ministerul Educatiei Nationale

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3